This is a statement endorsed by over 260 organisations. It criticises a change in the US treatment guidelines made in December 2009 which recommended antiretroviral treatment for people with CD4 counts less than 500 cells/mm3. The statement affirms the need for the START trial which will help determine the optimal point at which to begin antiretroviral treatment.
The following statement has been sent to the chairs of the United States Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents.
For media comment, please contact:... Read more